Parismita Kalita

About

Research focus: Understanding molecular mechanisms involved in host-virus interactions.

Employment

• Washington University in St. Louis Staff Scientist
  2025 - Present
• Washington University in St Louis Post Doctoral Research Associate
  2021 - 2024
• Indian Institute of Science Post Doctoral Fellow
  2019 - 2021
• North-Eastern Hill University Ph.D Scholar
  2014 - 2019

Education

• North-Eastern Hill University M.Sc.
  2011 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (28)

• Molecular basis for human respiratory syncytial virus transcriptional regulator NS1 interactions with MED25.
  Nature communications 2025 DOI: 10.1038/s41467-025-58216-4
  +Save
• Structure-guided engineering of CD112 receptor variants for optimized immunotherapy.
  Molecular therapy : the journal of the American Society of Gene Therapy 2025 DOI: 10.1016/j.ymthe.2025.04.032
  +Save
• Computational Protein Design for COVID-19 Research and Emerging Therapeutics
  ACS Central Science 2023 DOI: 10.1021/acscentsci.2c01513
  +Save
• From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics
  Journal of Physical Chemistry B 2023 DOI: 10.1021/acs.jpcb.3c04542
  +Save
• Functional expression, localization, and biochemical characterization of thioredoxin glutathione reductase from air-breathing magur catfish, Clarias magur
  International Journal of Biological Macromolecules 2023 DOI: 10.1016/j.ijbiomac.2022.123126
  +Save
• Immunoinformatics Protocol to Design Multi-Epitope Subunit Vaccines
  Methods in Molecular Biology 2023 DOI: 10.1007/978-1-0716-3239-0_25
  +Save
• Methodological advances in the design of peptide-based vaccines
  Drug Discovery Today 2022 DOI: 10.1016/j.drudis.2022.03.004
  +Save
• A highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative elicits high titers of neutralizing antibodies
  Biorxiv 2021 DOI: 10.1101/2021.01.13.426626
  +Save
• Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236](S0882401020305234)(10.1016/j.micpath.2020.104236)
  Microbial Pathogenesis 2021 DOI: 10.1016/j.micpath.2020.104401
  +Save
• Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
  Journal of Biological Chemistry 2021 DOI: 10.1074/jbc.RA120.016284
  +Save